Trials / Unknown
UnknownNCT06027047
Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Raivotech · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Sleep is not simply the absence of wakefulness. Sleep is an active procedure, normally happening every night, and is absolutely vital. Good sleep is essential for our well-being. Survival without food can be further than without sleep. Work time and commuting time seem to affect total sleep time and night bedtime. Social and work obligation can, therefore, suppress sleep time. Sleep deprived individuals may be facing anxiety and depression symptoms. The aim of this study is to investigate the presence of anxiety and depression symptoms among adults with the use of the smartphone application Onar. Onar app will be used to gather information from wearable devices of the users including total sleep time, sleep efficiency, wake after sleep onset time. An established questionnaire (Hospital Anxiety Depression Scale/ HADS) will be used to quantify and detect the presence of anxiety and depression in the study population.
Conditions
- Sleep Deprivation
- Sleep Hygiene
- Sleepiness
- Sleep Driving
- Depression, Anxiety
- Anxiety Disorders
- Depressive Symptoms
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2023-12-31
- Completion
- 2024-01-15
- First posted
- 2023-09-07
- Last updated
- 2023-09-07
Source: ClinicalTrials.gov record NCT06027047. Inclusion in this directory is not an endorsement.